1 June 2024 false Taxfiler 2024.6 15753661 business:PrivateLimitedCompanyLtd 2024-06-01 2025-06-30 15753661 2024-05-31 15753661 2024-06-01 2025-06-30 15753661 business:AuditExemptWithAccountantsReport 2024-06-01 2025-06-30 15753661 business:FilletedAccounts 2024-06-01 2025-06-30 15753661 2025-06-30 15753661 business:Director1 2024-06-01 2025-06-30 15753661 business:RegisteredOffice 2024-06-01 2025-06-30 15753661 core:WithinOneYear 2025-06-30 15753661 core:SharePremium core:PreviouslyStatedAmount 2025-06-30 15753661 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-06-30 15753661 core:PreviouslyStatedAmount 2025-06-30 15753661 business:SmallEntities 2024-06-01 2025-06-30 15753661 countries:EnglandWales 2024-06-01 2025-06-30 iso4217:GBP xbrli:pure
Company Registration No. 15753661 (England and Wales)
Med Pharma Developments Limited Unaudited accounts for the period from 1 June 2024 to 30 June 2025
Med Pharma Developments Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Med Pharma Developments Limited Company Information for the period from 1 June 2024 to 30 June 2025
Director
Stephen Jackson
Company Number
15753661 (England and Wales)
Registered Office
3a Blue Sky Way Monkton Business Park South Hebburn Tyne and Wear NE31 2EQ United Kingdom
Accountants
Abacus Accounting (NE) Limited 3a Blue Sky Way Monkton Business Park South Hebburn Tyne and Wear NE31 2EQ
- 3 -
Med Pharma Developments Limited Statement of financial position as at 30 June 2025
2025
Notes
£
Current assets
Debtors
4
90
Cash at bank and in hand
10
100
Creditors: amounts falling due within one year
5
(380)
Net current liabilities
(280)
Net liabilities
(280)
Capital and reserves
Share premium
100
Profit and loss account
(380)
Shareholders' funds
(280)
For the period ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 21 January 2026 and were signed on its behalf by
Stephen Jackson Director Company Registration No. 15753661
- 4 -
Med Pharma Developments Limited Notes to the Accounts for the period from 1 June 2024 to 30 June 2025
1
Statutory information
Med Pharma Developments Limited is a private company, limited by shares, registered in England and Wales, registration number 15753661. The registered office is 3a Blue Sky Way, Monkton Business Park South, Hebburn, Tyne and Wear, NE31 2EQ, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Debtors
2025
£
Amounts falling due within one year
Other debtors
90
5
Creditors: amounts falling due within one year
2025
£
Other creditors
380
6
Average number of employees
During the period the average number of employees was 0.
- 5 -